Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Recruiting N/A Interventional Study
Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes (MDS) Myeloproliferative Neoplasm
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
108 (estimated)
Sponsor
University of Nebraska · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and roles and worsen quality of life. Older adults undergoing hematopoietic cell transplantation (HCT) are at high-risk for cognitive impairment. Age is a risk factor for Alzheimer's Dementia (AD) and the hematological malignancies leading to HCT. There are shared mechanisms and int…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Arm 1: Inclusion Criteria for Participants: * age 60 years and older * have a diagnosis of hematological malignancy * have received autologous or allogeneic HCT within the prior 3-6 months * able to speak and read English * have provided written informed consent Exclusion Criteria for Participant…
Contacts

Marcia M Free, BSN

402-559-8151

marcia.free@unmc.edu

CONTACT

Thuy Koll, MD

402-559-7519

thuy.koll@unmc.edu

CONTACT